Skip to main content
. 2020 Apr 24;3(4):e203645. doi: 10.1001/jamanetworkopen.2020.3645

Table 1. Demographic Characteristics of Women With Breast Cancer and Women in the Subcohort From a Case-Cohort Study Within B ~ FIT.

Characteristic No. (%)
Breast cancer cases (n = 405) Subcohort (n = 495)
Age, y
<65 148 (36.5) 187 (37.8)
≥65 257 (63.5) 308 (62.2)
Race/ethnicity
Non-Hispanic white 384 (94.8) 469 (94.7)
Other 21 (5.2) 26 (5.3)
Group
Screened 323 (79.8) 371 (74.9)
FIT 69 (17.0) 98 (19.8)
FIT + FLEX 13 (3.2) 26 (5.3)
Family history of breast cancer in first-degree relative
No 316 (78.0) 419 (84.6)
Yes 81 (20.0) 61 (12.3)
Missing 8 (2.0) 15 (3.0)
BMI
<25.0 147 (36.3) 210 (42.4)
25.0-29.9 138 (34.1) 156 (31.5)
>30.0 116 (28.6) 125 (25.3)
Missing 4 (1.0) 4 (0.8)
Alcohol use in the last month
No 164 (40.5) 207 (41.8)
Yes 241 (59.5) 288 (58.2)
Parity
Nulliparous 51 (12.6) 46 (9.3)
1 47 (11.6) 60 (12.1)
≥2 306 (75.6) 389 (78.6)
Missing 1 (0.2) 0
Oral contraceptive use
Never 237 (58.5) 240 (48.5)
Ever 60 (14.8) 68 (13.7)
Missing 108 (26.7) 187 (37.8)
Duration of prior estrogen and/or progestin menopausal hormone therapy use, y
Never or <1 296 (73.1) 378 (76.4)
1-4 61 (15.1) 65 (13.1)
5-9 19 (4.7) 27 (5.5)
≥10 26 (6.4) 24 (4.9)
Missing 3 (0.7) 1 (0.2)
Quintile of circulating estradiol, pg/mL
Q1 (<6.30) 48 (11.9) 99 (20.0)
Q2 (6.30-8.61) 80 (19.8) 99 (20.0)
Q3 (8.62-12.64) 86 (21.2) 99 (20.0)
Q4 (12.65-18.70) 86 (21.2) 99 (20.0)
Q5 (>18.70) 105 (25.9) 99 (20.0)

Abbreviations: B ~ FIT, Breast and Bone Follow-up to the Fracture Intervention Trial; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); FIT, Fracture Intervention Trial; FLEX, FIT Long-term Extension Trial.

SI conversion factor: To convert estradiol level to picomoles per liter, multiply by 3.671.